SLAS Discovery and SLAS Technology Demonstrate Research Impact with 2024 Impact Factors

Open Access Publishing Expands Reach, Leading to Higher Citations and Visibility for SLAS Authors

Oak Brook, IL (July 11, 2025) – The Society for Laboratory Automation and Screening (SLAS) is pleased to announce the 2024 Journal Impact Factors (IF) for its two scientific journals, SLAS Discovery and SLAS Technology, as reported in the latest Journal Citation Reports (JCR) from Clarivate.

SLAS Technology achieved a substantial increase, rising 1.2 points to 3.7, highlighting its growing influence in the fields of laboratory automation and technology. SLAS Discovery remained firm with a 2.7 IF, reflecting its continued role as a trusted publication representing drug discovery and life sciences research.

“Reaching an impact factor of 3.7 was only possible through the collective effort of our authors, reviewers, special issue editors, editorial board members and the SLAS community,” says SLAS Technology Editor-in-Chief Edward Chow, PhD. “Thank you for allowing us to share impactful scientific research with the world.”

The 2024 impact factors increased due to Open Access publishing—a publishing model that makes the latest and most innovative research accessible to all readers and researchers.

Contributing authors have experienced increased visibility and citations with their published research. Researchers interested in submitting their work are encouraged to view the current list of calls for papers for upcoming Special Issues of SLAS Discovery and SLAS Technology.

*****

SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS Discovery reports how scientists develop and use novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. The journal focuses on drug discovery sciences with a strong record of scientific rigor and impact, reporting on research that:

• Enables and improves target validation
• Evaluates current drug discovery technologies
• Provides novel research tools
• Incorporates research approaches that enhance depth of knowledge and drug discovery success

SLAS Technology reveals how scientists adapt technological advancements for life sciences exploration and experimentation in biomedical research and development. The journal emphasizes scientific and technical advances that enable and improve:

• Life sciences research and development
• Drug delivery
• Diagnostics
• Biomedical and molecular imaging
• Personalized and precision medicine

SLAS Discovery: Advancing the Science of Drug Discovery, 2024 Impact Factor 2.7. Editor-in-Chief Robert M. Campbell, Ph.D., Grove Biopharma, Inc., Chicago, IL (USA)

SLAS Technology: Translating Life Sciences Innovation, 2024 Impact Factor 3.7. Editor-in-Chief Edward Kai-Hua Chow, PhD, KYAN Technologies, Los Angeles, CA (USA).

###